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Abstract
Background: There is little evidence of whether or not those who have attended cardiac rehabilitation (CR) are
meeting the physical activity guidelines recommended for secondary prevention of cardiovascular disease. In healthy
individuals, there is evidence, that even if individuals are meeting the physical activity guidelines, the harmfulness of
too much sedentary behaviour remains (active couch potato (ACP) phenomenon). Currently, there appears to be no
evidence of the ACP phenomenon in those attending CR. The aims of the study are to examine the level of physical
activity and sedentary behaviour in those with coronary heart disease (CHD) who have attended CR, and to investigate
the potential independent associations between these behaviours and cardio-metabolic health, health-related quality
of life, exercise capacity, anxiety and depression.
Methods: A prospective cohort study will be conducted in Australia over 12-months. Baseline data from this study
will contribute to an international, multi-centre cross-sectional study (Australia, New Zealand, United States of America,
South Africa, Spain, and Portugal). Adults currently enrolled in a 6-week phase II cardiac rehabilitation program with
stable CHD and receiving optimal medical treatment +/− revascularisation will be recruited. Outcome measures will be
taken at baseline (commence CR), 6 weeks (complete CR), 6 and 12-months. Physical activity and sedentary behaviour
will be measured using accelerometry and two questionnaires (Active Australia Survey, Past-Day Adults’ Sedentary
Time questionnaire). Health outcomes will include body mass index, waist-to-hip ratio, lipid profile, blood glucose
level, quality-of-life (MacNew), exercise capacity (6-min walk test), anxiety and depression (Hospital Anxiety and
Depression Scale).
Discussion: There has been limited investigation of the physical activity levels and sedentary behaviour of individuals
with CHD attending CR. There are no studies assessing the relationship of these behaviours with health outcomes over
the short and medium-term. As in healthy individuals, physical activity and sedentary behaviour may have independent
effects on cardiovascular risk factors in people with CHD, which may contribute to recurrent cardiovascular events. If this
is so, reducing sedentary behaviour may be a feasible first-line, additional and more achievable strategy to improve the
health of those with CHD, alongside traditional recommendations to increase the time spent in moderate-to-vigorous
intensity physical activity.
Trial registration: Australian New Zealand Clinical Trials Registry (ANZCTR): ACTRN12615000995572
Keywords: Coronary heart disease, Sedentary behaviour, Physical activity
* Correspondence: Nicole.Freene@canberra.edu.au
1Physiotherapy, Faculty of Health, University of Canberra, Canberra ACT 2601,
Australia
Full list of author information is available at the end of the article
© 2016 Freene et al. Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Freene et al. BMC Health Services Research  (2016) 16:75 
DOI 10.1186/s12913-016-1313-x
Background
Heart disease is the leading single cause of death of men
and women in Australia, and is prevalent worldwide [1, 2].
It is estimated that 34 % of all heart attacks in Australia
are repeat events [3]. Not only are repeat cardiac events
more likely to be fatal, they result in a higher burden of
disease cost than initial events, with the total economic
cost of repeat cardiac events in Australia amounting to
$8.4 billion in 2010 [3].
Internationally, it is recommended that all those with
coronary heart disease (CHD) be offered cardiac rehabilita-
tion (CR), a secondary prevention program. It is widely
recognised that CR decreases mortality, improves risk pro-
files, decreases hospital admissions, increases medication
adherence and improves quality of life [4–7]. CR programs
are usually exercise-based, consisting of either regular ex-
ercise alone, or a combination of exercise with education
and psychological support. Moderate-intensity aerobic ex-
ercise, or physical activity, is considered a core component
of CR [5, 8]. CR participants are encouraged to increase
their moderate-intensity aerobic physical activity slowly
and gradually, aiming to accumulate a minimum of 30 min
on most, or all, days of the week, throughout life [8]. How-
ever, little is known about how much physical activity these
individuals undertake outside of the CR program. It is not
clear whether CR participants’ are meeting the physical
activity guidelines as recommended for secondary preven-
tion, with some indication that only 8.4 min per day of
moderate-to-vigorous intensity physical activity (MVPA) is
achieved in the first 12 months following diagnosis of
CHD [9–11].
In healthy individuals, there is evidence that even if
you do enough physical activity to meet the recommen-
dations, by sitting too much (sedentary behaviour), the
harmfulness of too much sitting time remains (the
‘active couch potato’ (ACP) phenomenon) [12]. The few
prospective studies that have attempted to research this
phenomenon have reached the same conclusion: meet-
ing the public health guidelines regarding physical activ-
ity (150 min moderate-to-vigorous intensity aerobic
physical activity per week) may not necessarily protect
against the possible harmful effects from excessive
sedentary behaviour [12, 13]. It appears that the more
sedentary you are, the more likely you are to die from
any cause, with sedentary behaviour recently being
considered an independent risk factor for cardiovascular
disease and all-cause mortality [14–16]. There is also
some evidence that those with cardiovascular disease or
diabetes are more likely to die from any cause if they sit
for too long, independent of physical activity [17].
Therefore, it is important to take into consideration
sedentary behaviour when working towards secondary
prevention in those with CHD, intending to prevent fur-
ther cardiac events.
To our knowledge there are limited studies assessing the
effect of physical activity on health outcomes in people
with CHD, with no identified studies assessing the effect of
sedentary behaviour [18]. The general aim of the current
study is two-fold: a) to assess the physical activity levels
and sedentary behaviour (ACP phenomenon) outside the
clinic in participants attending a hospital-based phase II
CR program over 12 months, b) to assess the potential,
independent risk of this behaviour on the cardio-metabolic
health, health-related quality of life, exercise capacity,
anxiety and depression of CR participants.
Methods
Design
A prospective cohort study will be conducted in an
Australian hospital-based phase II CR program over 12-
months. Baseline data from this study will contribute to
an international, multi-centre cross-sectional study
(Australia, New Zealand, United States of America, South
Africa, Spain, and Portugal). At baseline, participants will
be assessed within the first 2 weeks after enrolment in the
phase II CR program. In Australia, participants will be
assessed again within 2 weeks of finishing the 6-week
phase II CR program, and at 6 and 12-months following
admission into the phase II CR program. The phase II car-
diac CR program included in this study is typical of most
contemporary CR programs in Australia. The CR program
is multidisciplinary, time-limited (twice a week, 6-weeks),
conducted in groups, hospital-based, and has educational
and supervised exercise components (one hour education
plus one hour exercise) [4].
Participants
Participants will be eligible to take part in the study if they
are aged 18+ and are currently enrolled in the hospital-
based phase II cardiac rehabilitation program. Participants
will be included if they have stable CHD and are receiving
optimal medical treatment +/− revascularisation, that is,
coronary artery bypass graft surgery, percutaneous translu-
minal coronary angioplasty or another transcatheter pro-
cedure, or have had a myocardial infarction. Participants
will be excluded if they have New York Heart Association
class II-IV symptoms of heart failure (or documented signs
and symptoms of chronic heart failure, with ejection frac-
tion < 45 %), uncontrolled arrhythmias, severe chronic
obstructive pulmonary disease, uncontrolled hyperten-
sion, symptomatic peripheral artery disease, unstable
angina, uncontrolled diabetes, are unable to perform a
submaximal walking test (6-min walk test), or are
unable to wear an accelerometer due to disability, for
example, if they are confined to a wheelchair. Eligible
participants must have adequate English language and
cognitive skills.
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Recruitment
CR nursing staff will recruit consecutive participants for
this study within CR sessions. CR Staff will identify
potential participants on admission to the phase II CR
program and will provide them with details of the study.
If potential participants are interested in taking part in
the study, CR nursing staff will determine whether they
are eligible according to the study inclusion and exclu-
sion criteria, and gain participants’ consent. The flow of
participants through the trial is illustrated in Fig. 1. The
principal investigator (PI) will visit the CR team prior to
participant recruitment and explain the study protocol
to all team members. The PI will remain in contact with
eligible participants and organise 6 and 12-month data
collection to maintain participant retention. If partici-
pants are lost to follow-up, any data that has been
collected will be used in the data analysis.
Outcome measures
All study measures will be collected at baseline, 6-weeks,
6 and 12 months. All assessments will be conducted at
the hospital where the CR program takes place, and will be
carried out by a trained health professional. This excludes
the blood samples, which will be collected at pathology
collection centres. The PI will ensure that all assessors
comply with data collection protocols to promote data
quality and minimise measurement error.
The main outcome measures are sedentary behaviour
and physical activity levels objectively measured using an
accelerometer. Subjective measures of sedentary behaviour
(Past-Day Adults’ Sedentary Time questionnaire, PAST)
and physical activity (Active Australia Survey, AAS) have
also been included in this study as they are commonly
employed as outcome measures in the clinical setting due
to their low cost and ease of use [19]. Haskell also suggests
that physical activity data is best interpreted by adopting a
combination of objective and subjective measures [20].
Dependent variables include body mass index (BMI),
waist-to-hip ratio (WHR), blood lipid and glucose levels,
exercise capacity (6-min walk test, 6MWT), quality of life
(MacNew Heart Disease Health-related Quality of Life
Questionnaire, MacNew) and anxiety and depression
(Hospital Anxiety and Depression Scale, HADS).
Sedentary behaviour and physical activity levels
Self-reported sedentary behaviour will be assessed using
the PAST [21]. The PAST is a seven-item instrument
that uses past-day recall of sedentary time. It asks about
time spent sitting or lying (while awake) on the previous
day with questions about time spent sitting or lying
while at work, travelling, watching television, using the
computer (excluding work), reading (excluding work),
hobbies, and any other purposes not reported in the pre-
vious items. The PAST questionnaire has been found to
have acceptable reliability and validity [21].
Self-reported physical activity will be assessed using the
AAS [22]. The AAS has been designed to measure partici-
pation in leisure time physical activity and to assess the
participant’s knowledge of current public health messages
about the health benefits of physical activity. It offers a
short and reliable set of questions and applies to 1 week
preceding the interview, including walking for transport.
The AAS has been reported as reliable and of acceptable
validity [23, 24].
A triaxial commercial accelerometer (ActiGraph GT3X,
Fort Walton Beach, FL) will be used to objectively assess
sedentary behaviour and physical activity. Accelerometers
allow an objective measurement of quantity and intensity
of movement and have been found to be reliable and valid
[25]. Participants will be asked to wear the monitor on
their right hip during a typical week for 24 h per day for 7
consecutive days. The raw data collected by the acceler-
ometer, counts, will be used to obtain the time spent in
different physical activity intensities [26]. We will use the
Freedson Combination energy expenditure algorithm to
Fig. 1 Flow of participants through the trial
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determine the intensity cut-points [27]. Sedentary behav-
iour will be defined as ≤ 100 counts per minute. This
outcome variable will be used to investigate whether par-
ticipants have reached the World Health Organisation
physical activity guidelines, and to calculate sedentary time.
Both the PAST and the AAS questionnaires will be
self-administered, and will be completed at the end of
the 7-day accelerometer wear time to cover the same
time period.
Anthropometric characteristics
Height (m), weight (kg) and BMI (kg/m2) will be recorded
using a calibrated set of scales and a stadiometer. Waist
circumference and hip circumferences will be measured in
centimetres using a tape measure.
Cardio-metabolic health
Fasting blood samples will be taken from participants and
will be analysed using the Abbott Architect Ci16200
system, according to the manufacturer’s guidelines. Each
sample will be assessed for a lipid standard panel (triglycer-
ides, total cholesterol, high-density lipoprotein- HDL and
non-HDL) and glucose level. Low-density lipoprotein will
be determined using the Friedewald formula [28]. Blood
pressure levels will be obtained using a mercury sphygmo-
manometer on the right arm of seated subjects.
Exercise capacity
The 6MWT is a commonly used objective measure of
functional exercise capacity in cardiac rehabilitation
[29]. The distance an individual is able to walk along a
flat 25–30 m walkway over a 6 min period, with breaks
as required, is recorded. The test is a self-paced, sub-
maximal test of exercise capacity, and has been found to
have a moderate-to-high reliability and validity [29].
A hospital-based exercise physiologist will perform
these assessments, monitoring heart rate, oxygen satu-
rations, the modified Borg rating of perceived exertion
scale, signs and symptoms throughout. The test may be
terminated by the participant or by the assessor if
criteria for termination of exercise testing are met.
Only one trial will be administered.
Health-related quality of life
The MacNew will be used for the assessment of heart
disease specific health-related quality of life [30]. The Mac-
New is self-administered and consists of 27 items which
fall into three domains (a 13-item physical limitations do-
main scale, a 14-item emotional function domain scale,
and a 13-item social function domain scale). There are 5
items that inquire about symptoms: angina/chest pain,
shortness of breath, fatigue, dizziness, and aching legs. The
time frame for the MacNew is the previous two weeks, and
it has good reliability and validity internationally [30].
Anxiety and depression
The HADS will be used for the assessment of anxiety
and depression [31]. This questionnaire is a 14‐item self‐
reporting questionnaire comprised of 4‐point Likert‐
scaled items covering the occurrence of symptoms of
anxiety (HADS‐A) and depression (HADS‐D) over the
past 2 weeks. Each item on the questionnaire is scored
from 0–3, so that a person can score between 0 (best
outcome) and 21 (worst outcome) for either anxiety or
depression.
Demographic and clinical questionnaire
Participants will be assessed on their socio-demographic
variables (i.e. gender, age, education level, relationship
status, current employment status) as well as clinical
predictor variables (i.e. cardiac-related medication, other
medical conditions, health care utilisation).
Eligible CR participants’ will be encouraged to adhere
to the CR program, with no additional encouragement
to change their physical activity and/or sedentary behav-
iour provided over the 12-month data collection period.
Sample size
The G*Power software v.3.1.9.2 was used to a priori
determine the required sample size. Previous recommen-
dations for sample size estimation in Multiple Linear
Regression problems were used [32]. With a desired effect
size of f2 = 0.5 (large), given a maximum of 10 predictor
variables including potential confounders, a sample size of
n = 59 is needed to achieve a power of 0.95 in a test based
on α = 0.05. Assuming a dropout rate of 25 %, 75 partici-
pants will be recruited for the Australian study.
Statistical analysis
The number of minutes per day spent in sedentary
behaviour will be calculated using standard count-based
intensity threshold values of counts per minute: < 100
for sedentary behaviour (<1.5 MET). Four further sum-
mary measures of sedentary behaviours will calculated per
day and averaged over valid days: (a) percentage of the
wear-day spent in sedentary behaviour (b) number of sed-
entary bouts (defined as a period of consecutive minutes
where the accelerometer registered <100 counts/minutes)
(c) average duration of sedentary bouts and (d) number of
sedentary breaks (defined as at least 1 min where the
accelerometer registered ≥ 100 counts/minute following a
sedentary bout). The Freedson Combination energy ex-
penditure algorithm will be used to determine the inten-
sity cut-points for MVPA. This outcome variable will be
used to investigate whether participants have reached the
World Health Organisation physical activity guidelines.
Linear regression models will be performed at each
data collection point, where the dependent variables will
be each of the health variables available. The models will
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have the different summary measures of sedentary
behaviour (i.e. one model will be performed with each
one) as main independent variables, and models will also
be performed for MVPA and each of the different phys-
ical activity intensities (i.e. light, moderate and vigorous
physical activity). If it is the case, quadratic trends might
be explored. The models will be adjusted for total time
of activity (i.e. counts per min ≥ 100), gender, socioeco-
nomics variables, BMI and other potential confounders
available.
Additional analyses will be completed with a one-way
repeated measures analysis of variance (ANOVA) to test
for differences in physical activity and sedentary behav-
iour (with a 95 % confidence interval (CI)) within the
Australian sample over 12 months. Intention-to-treat
analysis will be used at 6-weeks, 6 and 12-months where
data is missing, bringing the last value forward. A max-
imum of three attempts will be made to contact partici-
pants so outcome measures can be obtained, making the
analysis more complete.
Ethical approval
This study was approved by the ACT Health Human
Research Ethics Committee in August 2015 (Project
reference: ETH.5.15.076).
Trial status
Study protocol.
Discussion
Over 12 months we will assess the physical activity, seden-
tary behaviour levels and health outcomes of those with
CHD attending a hospital-based phase II CR program.
Specifically, we will measure the physical activity and sed-
entary behaviour levels of participants’ with CHD at the
start of a phase II CR program, at the end of the program,
and at 6 and 12-months to determine the short and
medium-term changes in physical activity and sedentary
behaviour levels. Few studies have determined whether
those attending CR achieve the public health physical ac-
tivity guidelines, as recommended, over the short and
medium term, and no known studies have reported on CR
participants’ sedentary behaviour, or sitting time. Import-
antly, we will also investigate the relationships between
physical activity, sedentary behaviour and health outcomes
at each point-in-time to determine the potential, inde-
pendent risk of these behaviours, including the potential
for the ACP phenomenon in CR participants.
One of the strengths of the trial is the pooling of baseline
results from multiple sites, internationally. Combining data
will increase the strength of statistical power analyses, with
the sample size to be recruited providing adequate statis-
tical power to detect relationships between the variables.
The Australian single cohort study is prospective, allowing
all the relevant information to be collected, including the
objective and subjective measurement of physical activity
and sedentary behaviour. The outcome measures are also
collected in a ‘real-world’ situation, reflecting common
practice for CR in Australia.
Limitations to the study include multiple assessors of
outcome measures despite assessors remaining consistent
for each outcome measure, for example, exercise capacity
will always be assessed by an exercise physiologist. There
is also a lack of randomisation, with recruitment of partic-
ipants occurring consecutively. Other possible limitations
include the potential for loss of participants to follow-up,
and few participants achieving the outcome of interest,
the ACP phenomenon.
One third of all heart attacks in Australia are repeat
events, they are more likely to result in death and are
costly. If sedentary behaviour is found to be an important
consideration for secondary prevention of CHD, reducing
sedentary behaviour, or sitting time, may be a feasible
additional or first-line strategy to improve the health of
those with CHD, alongside traditional recommendations to
increase the time spent in moderate-to-vigorous intensity
physical activity. Therefore, the outcomes from this study
may have implications for CR research, policy and practice,
and ultimately improve the health of those with CHD.
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